Detalhe da pesquisa
1.
Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies.
Future Oncol
; 17(27): 3549-3560, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34154392
2.
A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy.
Blood Adv
; 7(11): 2479-2493, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332004